Skip to main content

Main navigation

  • Home
  • Home
User account menu
  • Log in
By Editor , 19 September 2026

ZBeats Wins FDA Clearance for ZBPro v2.0, Expands ECG Analysis to 14 Days

ZBeats Wins FDA Clearance for ZBPro v2.0, Expands ECG Analysis to 14 Days

Stony Brook – September 18, 2026 -- ZBeats Inc. has secured U.S. Food and Drug Administration 510(k) clearance (K261580) for its ZBPro Diagnostic v2.0 software, extending its independent ECG analysis platform to cover recordings ranging from one minute to 14 days.

ZBeats Inc.